0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Investigation |  FREE
Lee M. Hampton, MD, MSc; Matthew Daubresse, MHS; Hsien-Yen Chang, PhD; et al.
JAMA Psychiatry. 2014;71(9):1006-1014. doi:10.1001/jamapsychiatry.2014.436.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Research Letter  | 
Capecitabine and the Risk of Fingerprint Loss
Leni van Doorn, MSc; Sebastiaan Veelenturf, MSc; Lisette Binkhorst, PharmD, PhD; et al.
JAMA Internal Medicine
Invited Commentary  | 
Medication Review After a Fracture—Absolutely Essential
Sarah D. Berry, MD, MPH; Douglas P. Kiel, MD, MPH
JAMA Internal Medicine
Original Investigation  | 
Patterns of Prescription Drug Use Before and After Fragility Fracture
Jeffrey C. Munson, MD, MSCE; Julie P. W. Bynum, MD, MPH; John-Erik Bell, MD, MS; et al.
JAMA Oncology
Original Investigation  | 
Incidence of Programmed Cell Death 1 Inhibitor–Related Pneumonitis in Patients With Advanced Cancer A Systematic Review and Meta-analysis
Mizuki Nishino, MD, MPH; Anita Giobbie-Hurder, MS; Hiroto Hatabu, MD, PhD; et al.